We are live on ! Find out more
THP

Tower House Partners Portfolio holdings

AUM $16.8M
1-Year Est. Return 41.98%
This Fund
S&P 500
This Quarter Est. Return
+37.48%
1 Year Est. Return
-41.98%
3 Year Est. Return
+21.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$207M
AUM Growth
+$71M
Cap. Flow
+$16M
Cap. Flow %
7.73%
Top 10 Hldgs %
100%
Holding
6
New
3
Increased
–
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$36.7M
2
BRKR icon
Bruker
BRKR
+$29.4M
3
CYRX icon
CryoPort
CYRX
+$10.1M

Top Sells

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$23.8M
2
BIO icon
Bio-Rad Laboratories Class A
BIO
+$22.1M
3
AZTA icon
Azenta
AZTA
+$14.3M

Sector Composition

Rank Sector Weight
1 Healthcare 93.37%
2 Industrials 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZTA icon
1
Azenta
AZTA
$1.21B
$47.6M 23%
1,075,000
-375,000
-26% -$14.3M
CRL icon
2
Charles River Laboratories
CRL
$10.8B
$40.1M 19.4%
+230,000
New +$36.7M
BIO icon
3
Bio-Rad Laboratories Class A
BIO
$8.15B
$38.4M 18.56%
85,000
-50,000
-37% -$22.1M
CTLT
4
DELISTED
CATALENT, INC.
CTLT
$36.6M 17.73%
500,000
-350,000
-41% -$23.8M
BRKR icon
5
Bruker
BRKR
$8.86B
$30.4M 14.68%
+746,253
New +$29.4M
CYRX icon
6
CryoPort
CYRX
$832M
$13.7M 6.63%
+452,972
New +$10.1M

Similar funds

RCGV
Ribbit Capital GP V Palo Alto, California $19.8M AUM
SCM
Stamina Capital Management New York $13.3M AUM 71.17% 1-Year Est. Return
CCA
Cross Creek Advisors Salt Lake City, Utah $20.5M AUM 54.22% 1-Year Est. Return
OHU
Odey Holdings (UK) London, United Kingdom $12.4M AUM 20.7% 1-Year Est. Return
OA
Oakhurst Advisors Los Angeles, California $21.3M AUM 8.8% 1-Year Est. Return
JM
Jeneq Management New York $22.3M AUM 47.87% 1-Year Est. Return
OP
Osmium Partners Greenbrae, California $10.4M AUM 73.79% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

Tower House Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Tower House Partners held 6 positions worth $207M, up 52% from $136M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tower House Partners deployed $16M of net new capital in Q2 2020, opening 3 new positions. Its largest new stake was Charles River Laboratories: 230,000 shares worth $40.1M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 100% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was CATALENT, INC., an estimated $23.8M trimmed.

  • Tower House Partners's largest Q2 2020 buy was Charles River Laboratories: 230,000 shares worth $40.1M.
  • Tower House Partners's biggest Q2 2020 reduction was CATALENT, INC., cutting an estimated $23.8M.
  • Tower House Partners's ten largest holdings make up 100% of its $207M portfolio in Q2 2020.
  • Tower House Partners opened 3 new positions and closed 0 in Q2 2020.
  • Tower House Partners's portfolio value rose 52% quarter-over-quarter to $207M.

Based on Tower House Partners's 13F filing for Q2 2020, filed 10 Aug 2020.